You just read:

Mallinckrodt Highlights First Patients in Company-Sponsored Prospective Observational Registry on the Use of H.P. Acthar® Gel (Repository Corticotropin Injection) Following Acute Multiple Sclerosis Relapse

News provided by

Mallinckrodt plc

May 25, 2017, 17:00 ET